A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

Status:
Completed

Trial end date:
2017-04-27

Target enrollment:

Participant gender:

To evaluate the effect of enzalutamide on prostate specific antigen (PSA) level in men with prostate cancer.

Phase 2

Astellas Pharma Inc

Medivation, Inc.

Hormones